<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Stratford Health Centre</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Stratford Health Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0502010A0&amp;denomIds=5.2.1&amp;selectedTab=summary">Posaconazole</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Triazole antifungals</td>
      <td>13</td>
      <td>0.23</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>41.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0502010A0AAABAB&amp;denomIds=5.2.1&amp;selectedTab=summary" target="_blank">Posaconazole 100mg gastro-resistant tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=1003020M0&amp;denomIds=10.3.2&amp;selectedTab=summary">Felbinac</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>324</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>14.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=1003020M0AAAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Felbinac 3% gel : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=1501030D0&amp;denomIds=15.1.3&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Antimuscarinic drugs</td>
      <td>3</td>
      <td>0.33</td>
      <td>0.0</td>
      <td>0.04</td>
      <td>7.37</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAD8ElEQVR4nO3dz4tbVRjG8e+puqoOCEpREaOiG6GKuhmtWoR2M+LClRtxMVBcCa6Me5ERN0URBkFR/wFdGESQ2hbEbloVl3YxLlQsKGrxBwi+LpKFTdN2kvve3FzO97NLSN55yOSZc3JzJykRgaQ67Ok6gKTlsfBSRSy8VBELL1XEwksVsfBSRSy8VBELL1XEwksVsfBSRSz8MpTi+ctaCRZeqkijwg+Go7WsIJLa13SFP5gRQtJyNC384ZQUkpaiaeEPpaSQtBRNC//nYDi6PSWJpNY1LfwnuMpLvdG08CeAAxlBJLWvaeG/A27JCCKpfU0L/yNwc0YQSe1rWvhfgeszgkhqX6PC72xtBPDHYDi6NimPpBZlnEv/A3BTwhxJLbPwUkWyCu+BO6kHLLxUkYzC+9ac1BOu8FJFLLxUEQsvVSSj8OeBtcFwVBJmSWpR48JPzrb7HbiueRxJbcr61FpPvpF6IKvwvjUn9UDmCm/hpRWXVfjvgVuTZklqSVbhvwH2J82S1JKswp8BHkiaJaklKYXf2dr4GbjGr56SVlvml0l+CdyXOE9SsszCnwHuT5wnKVlm4U/j63hppbnCSxVJK/zO1sY5YO9gONqbNVNSrswVHuBr4MHkmZKSZBf+TWB7MBztS54rKUGJiNSBg+HoGeAF4HXgJ+CfqZvM+oHT1+WG6tjOq08cG7z40eNd52iRn4WwRDtbG8cWvW+jwpdSjkTEWwsPWLK+5YX+Ze5bXuhf5iZ5m27pjzS8/7L1LS/0L3Pf8kL/Mi+cN/s1vKQVZuGlijQtfG9e90z0LS/0L3Pf8kL/Mi+cN/0ovaTV5ZZeqsjV89y4lPIo8BBwLiLeKaU8BdwJnI2ID9oI2NSMzM8C9wAfR8Rn3aa72HTeyXXbwLsRcarTcJcw4zF+BFgHTkXEyW7TXWxG3k0mH7MeEUc7DXcJpZSDwHMR8fTk8iawDzgREZ/vds68K/x6RGwBN04u3xURrwF3zzlnmS7IHBHvAdvAHZ2murQL8k7+qB7vNNGVTT8vngT+Av7tLtJlTee9inF5znUX6fIi4jjw1f+uuiEiXgEOzDNn3sL38Yy4CzKWUvYCm8D73cS5ounHdD/jX+rDHWTZrenMaxHxBnC4izC7MJ13T0S8xHi32hcLdW+ug3aTrdA68Avjf4e9jfGD9G1EfLhIgLbNyPw8cBb4NCK+6DLbLNN5I+L0ZDv394pv6aefFwPgt4h4u8NoM83I+xjj04PPr+oZd6WUe4GXgVOMF6tDjHclJ+fZ0nuUXqqIR+mlilh4qSIWXqqIhZcqYuGlilh4qSIWXqqIhZcqYuGlilh4qSIWXqrIf3wMEtxTQ4uWAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=1501030D0AABDBD&amp;denomIds=15.1.3&amp;selectedTab=summary" target="_blank">Atropine 3mg/10ml solution for injection pre-filled syringes : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=130400000&amp;denomIds=13.4&amp;selectedTab=summary">Other topical corticosteroid preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Topical corticosteroids</td>
      <td>452</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.00</td>
      <td>5.97</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=130400000AABLBL&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Propylene glycol 40% in Clobetasol 0.05% cream : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0105010C0&amp;denomIds=1.5.1&amp;selectedTab=summary">Olsalazine sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Aminosalicylates</td>
      <td>73</td>
      <td>0.08</td>
      <td>0.0</td>
      <td>0.01</td>
      <td>5.68</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFB0lEQVR4nO3dTWgcdRjH8e+/Fa1J60tFexBlVCxCrYqtSl8QERFhcyh6koIehOpJBF+yUC++ICsieFAUlUp7FAQLDlIrjfQgUeKhYKOWQBcKFXNIqiG2tiSPh5niNuRld/P8N4P/3weGbHe6zzP/2f3tzA6zs8HMEJE0rFrpBRCR3lHgRRKiwIskRIEXSYgCL5IQBV4kIQq8SEIUeJGEKPAiCVHgRRKiwFdVCDrnWdy5BT6r5/u9aolIHJ5b+Keyen61Yz0Rcea9S7/JuZ6IOPIM/HHgTsd6IuLMM/CfocCLVJpn4A+hwItUmmfgTwAbHeuJiDO3wDcbtfPAZFbPb/CqKSK+vI/S/4x260UqK0bgNzvXFBEn2sKLJESBF0mId+BPArdk9Tw41xURB66BbzZqs8Ap4GbPuiLiI8bXY7VbL1JRCrxIQhR4kYQo8CIJiRH408CGrJ5fFqG2iCyDe+CbjZoBo2grL1I5sS5i+QNwf6TaItKlWIH/EXggUm0R6VLMwGsLL1IxUQLfbNR+B9Zm9XxdjPoi0p2YP0QxAmyNWF9EOhQz8DpwJ1IxMQOvA3ciFRMz8D8BWyLWF5EORQt8s1GbBs5k9fzGWD1EpDOxfz1Wn+NFKiR24PU5XqRCtIUXSUjswI8Cd2T1fHXkPiLShqiBbzZqM8D3wAdZPe+P2UtElhZ7Cw/wJPAHMJLV8+096CciCwhm1pNGWT2/D9gH9AGT5TQFnAPOzvk7Dfy1xHSu/O79/1MIhpku9y2uehZ4gPJ69VcC1wLrgbXAmvK+1r/9wDrgqkWmvpbSBpwH/pkzzXffxekCMFs+drZHt9t+TPPtgYPZ4FcD86zG+Z4w7/s6tdwaVVgGjxorsgFqNmpDbf9nM3OZgD1etVa6j8ZSzT4ay/Inz8/wexxrrXQfjaWafTSWZerFQTsRqQgFXiQhnoH/2LHWSvfRWKrZR2NZpp4epReRlaVdepGEdPTrMCGEB4HtwLiZ7QshPA7cBowBx4HdFCfUvA+8WT5sr5nNOPY5U86bAo5SHO38xsy+dOxhFNfjOwIcA14CzprZ6530aKPPKWBnOf8tx7HsAh4zs+da5wEHncfS2mcXcA9wAvibcv2Z2RHnPi9QbKiOUpyAtRuYNLP3HHs8DNwFbAJy57E8Xdb9GpjB6blpV6db+G1m1gCuL/99u5m9A2wEahQhvwK4GzgMfFve7tSCfcxsCGgA11GcWDPFpSfheIxlmuLEnDXAQ8CnwOkQwnrnsYwAnwNDnmMp3zCa88xzHUtrn/L2u8BNXLr+urHYeCaAyyk2Vq2vObceZbCHKULoPZb9wEfArfg+N23pNPBzP/DHOgCwVJ9XgE/MbNTMBilWnlsPMztsZq8B93ZRt+0+pSeAL5zH0u48tz4hhNUUz8uHDutvwT5mdqAMySNd1l6yR+lR4JD3WEII/cAzwIE2lsFdpz/4OBxCGAQmQghbgLEQwsvAb8AvwF6KXfpjwBvlY17tYrkW7BNCeJby3TGE8CswAHTz9dvFeuykeMf9E/gOeJFiV2vCs085f4OZjYcQNjuOpQ/YEULY0TJvPMJYWvvUKF5P20II0/y3/rqxWJ9rKHaxxyguhX7xNefZYxhYZWYX5rwWPMbyfLnsW/F9btqio/QiCdFRepGEKPAiCVHgRRKiwIskRIEXSYgCL5IQBV4kIQq8SEIUeJGEKPAiCVHgRRLyL6rWHk7PR9ilAAAAAElFTkSuQmCC"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0105010C0AAAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Olsalazine 250mg capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0105010C0AAADAD&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Olsalazine 500mg tablets : 5</a></div></td></tr></tbody></table>

        <h2>Prescribing where Stratford Health Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0&amp;denomIds=7.3.1&amp;selectedTab=summary">Combined ethinylestradiol 30mcg</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>43</td>
      <td>Combined hormonal contraceptives</td>
      <td>80</td>
      <td>0.54</td>
      <td>0.81</td>
      <td>0.07</td>
      <td>-3.68</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0BBAAAA&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Marvelon tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0BRAAAE&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Millinette 30microgram/75microgram tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0AAAEAE&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Ethinylestradiol 30microgram / Gestodene 75microgram tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0AAAJAJ&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Ethinylestradiol 30microgram / Drospirenone 3mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0BEABAH&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Microgynon 30 ED tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0BPAAAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Rigevidon tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0BEAAAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Microgynon 30 tablets : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0AAAAAA&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Ethinylestradiol 30microgram / Desogestrel 150microgram tab : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0AAACAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Ethinylestradiol 30microg / Levonorgestrel 150microg tab : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0703010F0BNAAAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Levest 150/30 tablets (Morningside) : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=1310040Q0&amp;denomIds=13.10.4&amp;selectedTab=summary">Permethrin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Parasiticidal preparations</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.84</td>
      <td>0.25</td>
      <td>-3.32</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>19</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>24</td>
      <td>0.79</td>
      <td>0.95</td>
      <td>0.07</td>
      <td>-2.36</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFYklEQVR4nO3dXYgWVRzH8e/YEr25BBbaqxNRVGZbEMRmZi9Y1oiVGXRhkhrWVXfFeBFERM1VCBVElL3dFCUYMlYXwWpli2B0ERVRNlpYCPmaL1D07+LMxuP2uOqzM3POOr8PHHafh+XMby9+nLPzzMxGZoaItMMk3wFEpDkqvEiLqPAiLaLCi7SICi/SIiq8SIuo8CItosKLtIgKL9IiKrxIi6jwEpYo0rXeNerzHUBEji1O88uAt4CtRZYs7nUeFV5kYngU+AgYHs8kke6Wk6BEkWEW+Y4RkjjNTwV+BAaKLNk9nrn0N7xI+BYAG8ZbdlDhRSaCR4DXqphIhRcJWJzm04EY2FjFfCq8SNiWAm8UWVLJyTadpRcJVJzmEbAYmF3VnFrhRcJ1PbC9yJLfqppQhRcJ1yLggyon1JZeJEDldn4hFW7nQSu8SKiuA3YUWfJ7lZOq8CJhegB4v+pJtaUXCUzHdv7WqufWCi8SngFgZ5ElO6qeWIUXCc9S4N06JtaWXiQgcZqfB9wDXFXH/FrhRcLyJPBSkSUH65hcK7xIIOI0nwbcB8yo6xha4UXC8QTwcpElB+o6gFZ4kQDEaT4DuB+4us7jaIUX8SxO85nAOmBJkSV/1nksFV7EozjNrwU+BB4qsqSSh1yMRVt6EQ/iNL8AWAncDSwusmRTE8dV4UUaUl4yOwtYhrtsdhUwo8iSQ01l0GOqJSwn4WOq4zQ/H1gCPAz8AqwG1jZZ9BFa4UVqUD5Lfj5uNb8CeAeYV2RJ4TOXVngJywRe4eM07wPm4D5em4970uxqYKjIkn98ZhuhwktYJljhy5X8dlzJ7wS2AGuAdUWW7PGZrRsVXsIyAQofp/kZwFxcyW8DNuGePbe+7s/Rx0uFl7AEWvjyH0Ik5RgAhnAr+Sd13ehSBxVewhJI4cvbVG/EfYw2FzAgL8dwkSV/e4zXMxVewtJw4cvPxqcBV+LuUrsBGAQO4rbqm3An3bY1lalOKryEpYbCx2k+GbiwY1wETMeV/BJgJ/Ad8C2wGbeCB3fCrQoqvITlOAtfrsxnAv3AFI4sdOeYAuwHfh01tgPfAz9P1O15L3ThjTSiLOhpuJJ2G/1Af+F+9pmR1+WYPOp1H+5v6gPAPmA37gq2kTJv7vh+V1X/iPFkcEKFj9P8rvLbSF8r+err2H1dxilHeX88P9P5OxpwGFfSbmNfOcCVd1/H2N/5fZElfyG9MbNGB7Ci6WOGnENZlKXJLD7uh1/h4ZjdhJIDlOVolKW7nrPoARgiLaLCi7SIj8K/6uGY3YSSA5TlaJSlu56z6HN4kRbRll6kRWq/8CaKoptxNyHsNLPV5XuvAG+a2XDdxx8rSxRFTwN7gPVm9oPnLLNx13APm1ntTy89RpZ7cf/b7HQze8pzluW4C28ws1WesywDzga2mdmahrPcAjxmZg+Wr5cDU4ENZvbF8c7TxAo/aGYZcC5AFEULcbcW+nBEFuAP3FVeIWRZABwCfDwZ5YgsZrYW+Al4z3cW3IU8U3HXu/vOcrGZvQDMazqImQ0BX3e8dY6ZPQfcdCLzNFH40ScJrsGFnNXAscfMYmYvAs8Di3xnAfrLPHcEkAVgppl903iS/2eZZGYrgUsDyPJpFEWPA3s9ZBmtp5NvtZ+0K7dFg8Au4Csz21JuTw572tL/lwW4HHdL5Odm9rHnLNOBGNhrZq97zrIVWFquZo3qkmUO7tLc/WbW6JnyLlnOwt0++6WZfdZwlgHgWWAYeBt3j/5UYOOJbOl1ll6kRXSWXqRFVHiRFlHhRVpEhRdpERVepEVUeJEWUeFFWkSFF2kRFV6kRVR4kRZR4UVa5F+z7LFhFrbZ2QAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0407042Q0&amp;denomIds=4.7.4&amp;selectedTab=summary">Pizotifen malate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Prophylaxis of migraine</td>
      <td>21</td>
      <td>0.05</td>
      <td>0.65</td>
      <td>0.26</td>
      <td>-2.31</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0407042Q0AAABAB&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Pizotifen 500microgram tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0607010C0&amp;denomIds=6.7.1&amp;selectedTab=summary">Cabergoline</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Bromocriptine and other dopaminergic drugs</td>
      <td>4</td>
      <td>0.25</td>
      <td>0.86</td>
      <td>0.27</td>
      <td>-2.24</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F84022&amp;numIds=0607010C0AAAAAA&amp;denomIds=6.7.1&amp;selectedTab=summary" target="_blank">Cabergoline 500microgram tablets : 1</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>